How to use an article about genetic association - C: What are the results and will they help me in caring for my patients?

JAMA

Volumn 301, Issue 3, 2009, Pages 304-308

  Attia, John ^a,b   Ioannidis, John P A ^c,d   Thakkinstian, Ammarin ^e   McEvoy, Mark ^a   Scott, Rodney J ^f,g   Minelli, Cosetta ^h   Thompson, John ⁱ   Infante Rivard, Claire ^j   Guyatt, Gordon ^k  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c UNIVERSITY OF IOANNINA   (Greece)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MAHIDOL UNIVERSITY   (Thailand)

^f JOHN HUNTER HOSPITAL   (Australia)

^g UNIVERSITY OF NEWCASTLE   (Australia)

^h NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

ⁱ UNIVERSITY OF LEICESTER   (United Kingdom)

^j MCGILL UNIVERSITY   (Canada)

^k MCMASTER UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; BEHAVIOR CHANGE; CLINICAL PRACTICE; DIAGNOSTIC TEST; ETHNIC GROUP; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MEDICAL LITERATURE; PATIENT CARE; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; VALIDITY; ARTICLE; CLINICAL MEDICINE; GENETIC LINKAGE; GENETIC MARKER; GENETIC SCREENING; INHERITANCE; LITERATURE; MEDICAL GENETICS; PUBLICATION; REPRODUCIBILITY;

CLINICAL MEDICINE; GENETIC MARKERS; GENETIC SCREENING; GENETICS, MEDICAL; HUMANS; INHERITANCE PATTERNS; LINKAGE (GENETICS); PERIODICALS AS TOPIC; REPRODUCIBILITY OF RESULTS; REVIEW LITERATURE AS TOPIC;

EID: 58749099119     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2008.993     Document Type: Review

References (31)

1. Attia J, Ioannidis JPA, Thakkinstian A, et al. How to use an article about genetic association: A: background concepts. JAMA. 2009;301(1):74-81.
2. Attia J, Ioannidis JPA, Thakkinstian A, et al. How to use an article about genetic association: B: are the results of the study valid? JAMA. 2009;301(2):191-197.
3. Slooter AJC, Cruts M, Hofman A, et al. The impact of APOE on myocardial infarction, stroke, and dementia: the Rotterdam study. Neurology. 2004;62(7):1196-1198.
4. Guyatt G, Rennie D, eds. Users' Guides to the Medical Literature: A Manual for Evidence-Based Practice. Chicago, IL: American Medical Association; 2002.
5. Zollner S, Pritchard JK. Overcoming the winner's curse: estimating penetrance parameters from case-control data. Am J Hum Genet. 2007;80(4):605-615.
6. Ioannidis JPA, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet. 2001;29(3):306-309.
7. Yang Q, Khoury MJ, Friedman JM, Little J, Flanders WD. How many genes underlie the occurrence of common complex diseases in the population? Int J Epidemiol. 2005;34(5):1129-1137.
8. Zheng SL, Sun J, Wiklund F, et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med. 2008;358(9):910-919.
9. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. http://www.alzgene.org. Accessed October 25, 2008.
10. Kathiresan S, Melander O, Anevski D, et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med. 2008;358(12):1240-1249.
11. Irwig L, Bossuyt P, Glasziou P, Gatsonis C, Lijmer J. Designing studies to ensure that estimates of test accuracy are transferable. BMJ. 2002;324(7338):669-671.
12. Humphries SE, Ridker PM, Talmud PJ. Genetic testing for cardiovascular disease susceptibility: a useful clinical management tool or possible misinformation? Arterioscler Thromb Vasc Biol. 2004;24(4):628-636.
13. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study. Circulation. 2002;105(3):310-315.
14. Cupples LA, Farrer LA, Sadovnick AD, Relkin N, Whitehouse P, Green RC. Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL Study. Genet Med. 2004;6(4):192-196.
15. Mayeux R, Saunders AM, Shea S, et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease: Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N Engl J Med. 1998;338(8):506-511.
16. Emmerich J, Rosendaal FR, Cattaneo M, et al; Study Group for Pooled-Analysis in Venous Thromboembolism. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Thromb Haemost. 2001;86(3):809-816.
17. Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med. 2004;117(1):19-25.
18. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995;332(14):912-917.
19. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993;342(8886-8887):1503-1506.
20. Myers RH, Schaefer EJ, Wilson PWF, et al. Apolipoprotein E epsilon 4 association with dementia in a population-based study: the Framingham Study. Neurology. 1996;46(3):673-677.
21. Allele Frequency Database. Gene frequency data on human populations. http://alfred.med.yale.edu/alfred/index.asp. Accessed December 16, 2008.
22. International HapMap Project. HapMap. http://www.hapmap.org/. Accessed December 16, 2008.
23. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266(5182):66-71.
24. National Comprehensive Cancer Network. Testing of women with breast or ovarian cancer. http://www.nccn.org. Accessed December 16, 2008.
25. McLeod HL, Krynetski EY, Relling MV, Evans WE. Genetic polymorphisms of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia. 2000;14(4):567-572.
26. Marteau TM, Lerman C. Genetic risk and behavioural change. BMJ. 2001;322(7293):1056-1059.
27. Hamajima N, Suzuki K, Ito Y, Kondo T. Genotype announcement to Japanese smokers who attended a health checkup examination. J Epidemiol. 2006;16(1):45-47.
28. Lipkus IM, McBride CM, Pollak KI, Lyna P, Bepler G. Interpretation of genetic risk feedback among African-American smokers with low socioeconomic status. Health Psychol. 2004;23(2):178-188.
29. Scheuner MT, Sieverding P, Shekelle PG. Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA. 2008;299(11):1320-1334.
30. Hunter DJ, Khoury MJ, Drazen JM. Letting the genome out of the bottle - will we get our wish? N Engl J Med. 2008;358(2):105-107.
31. Janssens AC, Gwinn M, Bradley LA, Oostra BA, van Duijn CM, Khoury MJ. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet. 2008;82(3):593-599.